Adagio Medical Holdings (ADGM) Free Cash Flow (2023 - 2026)

Adagio Medical Holdings (ADGM) has 4 years of Free Cash Flow data on file, last reported at -$4.1 million in Q1 2026.

• Free Cash Flow for Q1 2026 came in at -$4.1 million, up 45.56% year-over-year; the trailing twelve-month figure through Mar 2026 was -$7.7 million (up 63.1% YoY), and the FY2025 annual result was -$19.4 million, down 31.45% from the prior year.
• Free Cash Flow fell to -$4.1 million in Q1 2026 per ADGM's latest filing, from -$3.6 million in the prior quarter.
• Over five years, Free Cash Flow peaked at -$3.6 million in Q4 2025 and troughed at -$7.5 million in Q1 2025.
• A 4-year average of -$6.1 million and a median of -$6.8 million in 2023 frame the typical range for Free Cash Flow.
• The sharpest annual moves came in 2025 and 2026: Free Cash Flow fell 9.81% in 2025, then surged 45.56% in 2026.
• A 4-year view of Free Cash Flow shows it stood at -$6.8 million in 2023, then fell by 2.84% to -$7.0 million in 2024, then soared by 47.74% to -$3.6 million in 2025, then declined by 12.48% to -$4.1 million in 2026.
• Business Quant data shows ADGM's Free Cash Flow at -$4.1 million in Q1 2026, -$3.6 million in Q4 2025, and -$7.5 million in Q1 2025.